title: Impact of Health Insurance Expansion on the Treatment of Colorectal Cancer.
abstract: Purpose Colorectal cancer is the third most common cancer and the third leading cause of cancer deaths in the United States. Lack of insurance coverage has been associated with more advanced disease at presentation, more emergent admissions at time of colectomy, and lower survival relative to privately insured patients. The 2006 Massachusetts health care reform serves as a unique natural experiment to assess the impact of insurance expansion on colorectal cancer care. Methods We used the Hospital Cost and Utilization Project State Inpatient Databases to identify patients with colorectal cancer with government-subsidized or self-pay (GSSP) or private insurance admitted to a hospital between 2001 and 2011 in Massachusetts (n = 17,499) and three control states (n = 144,253). Difference-in-differences models assessed the impact of the 2006 Massachusetts coverage expansion on resection of colorectal cancer, controlling for confounding factors and secular trends. Results Before the 2006 Massachusetts reform, government-subsidized or self-pay patients had significantly lower rates of resection for colorectal cancer compared with privately insured patients in both Massachusetts and the control states. The Massachusetts insurance expansion was associated with a 44% increased rate of resection (rate ratio = 1.44; 95% CI, 1.23 to 1.68; P < .001), a 6.21 percentage point decreased probability of emergent admission (95% CI, -11.88 to -0.54; P = .032), and an 8.13 percentage point increased probability of an elective admission (95% CI, 1.34 to 14.91; P = .019) compared with the control states. Conclusion The 2006 Massachusetts health care reform, a model for the Affordable Care Act, was associated with increased rates of resection and decreased probability of emergent resection for colorectal cancer. Our findings suggest that insurance expansion may help improve access to care for patients with colorectal cancer.
authors.affiliation: All authors: Massachusetts General Hospital, Boston, MA.
authors.forename: Andrew P
authors.initials: AP
authors.lastname: Loehrer
authors.affiliation: All authors: Massachusetts General Hospital, Boston, MA.
authors.forename: Zirui
authors.initials: Z
authors.lastname: Song
authors.affiliation: All authors: Massachusetts General Hospital, Boston, MA.
authors.forename: Alex B
authors.initials: AB
authors.lastname: Haynes
authors.affiliation: All authors: Massachusetts General Hospital, Boston, MA.
authors.forename: David C
authors.initials: DC
authors.lastname: Chang
authors.affiliation: All authors: Massachusetts General Hospital, Boston, MA.
authors.forename: Matthew M
authors.initials: MM
authors.lastname: Hutter
authors.affiliation: All authors: Massachusetts General Hospital, Boston, MA.
authors.forename: John T
authors.initials: JT
authors.lastname: Mullen
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D015179:Colorectal Neoplasms / Q000453:epidemiology / Q000628:therapy*; D005260:Female; D018166:Health Care Reform; D006297:Health Services Accessibility; D054625:Healthcare Disparities; D006801:Humans; D019458:Insurance Coverage; D008297:Male; D008404:Massachusetts / Q000453:epidemiology; D008875:Middle Aged; D058991:Patient Protection and Affordable Care Act; D014481:United States / Q000453:epidemiology